Skip to content

SOP 21.027

Development and Maintenance of an Investigator’s Brochure for IMP/ATIMPs owned by Co-Sponsor   For Password contact Lead Pharmacist Clinical Trials R&I

GUI 51.002A

Participant Information Sheet and Informed Consent Form Guidelines

SOP 21.025

Management of Dose Escalation in Early Phase IMP/ATIMP Clinical Trials   For Password contact Lead Pharmacist Clinical Trials R&I    

FORM 21.025G

Green to Dose Checklist   For Password contact Lead Pharmacist Clinical Trials R&I